Navigation Links
MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute
Date:4/11/2011

SAN DIEGO, April 11, 2011 /PRNewswire/ -- MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant (SBIR) from the National Cancer Institute (NCI) under the agency's Streamlined Non-competing Award Procedures (SNAP). The initial year 1 grant of $150,000 was awarded on August 1, 2010 and supported the manufacture and testing of the company's sarcoma vaccine currently in clinical testing. The follow-on grant is intended to help support the Phase II clinical trial of the company's vaccine to prevent recurrent sarcoma.  The year 2 award is for $974,000 and the year 3 award is for an additional $878,000.  

"We are very gratified that the NCI has made this follow-on award to MabVax.  These grants will significantly help offset the costs of the Phase II trial such as investigational site and certain patient care expenses," said David Hansen, CEO of MabVax.  He added that "the trial now has 10 active sites enrolling patients and we have made good progress toward reaching our enrollment goals."

The Phase II clinical trial will enroll a total of 134 metastatic sarcoma patients in a randomized, multicenter, double-blind study of the trivalent vaccine specifically developed to target and kill residual circulating cancer cells and micrometastases thought to cause recurrent sarcoma.  In the United States (US), there are approximately 13,200 sarcoma cases diagnosed each year, representing less than 1% of all new cancers.  Prognosis remains poor, with more than 5,200 patients in the US dying of the disease each year.  As in other malignancies, disease recurrence and metastasis are common in sarcoma.  Despite undergoing potentially curative surgical resection or combination t
'/>"/>

SOURCE MabVax Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute
2. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
3. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
4. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
5. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
6. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
7. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
8. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
9. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
10. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
11. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... -- Kainos Capital, a firm specializing in acquiring and managing ... acquired the Slim-Fast brand from Unilever. Unilever will retain ... transaction were not disclosed. Slim-Fast is a ... ready-to-drink shakes, powders, bars and snacks to retail customers ... the United Kingdom and Ireland.  ...
(Date:7/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/s3bqj2/photonic ) ... Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module ... to their offering. ... integration traces its roots in the latter half ... integration went unexplored and unfulfilled for several decades ...
(Date:7/10/2014)... 15, 2014 -- According to the International Atomic ... security comes from terrorists acquiring sufficient quantities of ... a crude nuclear explosive device. The IAEA also ... have involved gram-level quantities, which can be challenging ... to a new study appearing this week in ...
(Date:7/10/2014)... June 17, 2014 Using microscopic polymer light ... gases, researchers at MIT,s Quantum Photonics Laboratory have ... in the parts-per-billion range. Optical sensors are ideal ... high signal-to-noise ratio, compact, lightweight nature, and immunity ... sensors had been developed before, the MIT team ...
Breaking Biology Technology:Kainos Capital Acquires Slim-Fast From Unilever 2International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Sensitive detection method may help impede illicit nuclear trafficking 2Swell new sensors 2
... BioPharma Have Entered into an Agreement Under, Which Genmab Will ... ... USA, COPENHAGEN, Denmark and REDWOOD CITY, California, February 21, ... ) announced today that they have entered into an agreement,under ...
... a,global provider of products and services that improve the ... by the New York,Department of Health for its public ... to maintain emergency response readiness, New,York has purchased more ... two years., Cardinal Health has already shipped 850 ...
... (OTC,Bulletin Board: SNKTY), a Life Sciences company engaged ... of healthy aging, today announced,that Dr. Mark Nestor ... Symposium in Miami., In his presentation to ... attributes of Pyratine-6(TM) for the treatment of,photodamaged skin ...
Cached Biology Technology:Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 2Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 3Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 4Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility 5New York Strengthens Emergency Preparedness with Cardinal Health Ventilators 2Dr. Mark Nestor Presents on Pyratine-6(TM) at the South Beach Symposium 2Dr. Mark Nestor Presents on Pyratine-6(TM) at the South Beach Symposium 3
(Date:7/14/2014)... 14, 2014 MedNet Solutions , ... clinical study management systems, is pleased to announce ... firm focused on software-as-a-service (SaaS) and Internet-based businesses, ... Solutions.  This funding, representing the first major outside ... in supporting the ongoing growth and development of ...
(Date:7/14/2014)... July 14, 2014 Research and Markets ... Testing 2014: Applications for Microfluidic Technologies" report to their ... POC testing based on microfluidic technology is expected to grow ... a CAGR 2014 - 2019 of 23%. Major diagnostics companies ... Abaxis, etc.) have realized the potential of rapid molecular diagnostic ...
(Date:7/14/2014)... deadly diseases and infections, such as tuberculosis and ... speed up the drug discovery process. , In ... , University of Illinois researchers developed a new ... produced by bacteria. , Past techniques involved screening ... product, said principal investigator Doug Mitchell, assistant professor ...
Breaking Biology News(10 mins):Arrowroot Capital Invests $4 Million In MedNet Solutions 2Arrowroot Capital Invests $4 Million In MedNet Solutions 3Applications for Microfluidic Technologies in Point of Care Testing: 2014 Report 2Applications for Microfluidic Technologies in Point of Care Testing: 2014 Report 3Innovative technique may transform the hunt for new antibiotics and cancer therapies 2Innovative technique may transform the hunt for new antibiotics and cancer therapies 3
... SANTA CRUZ, CA--The emerging field of "personalized" or ... cancer. If scientists can identify the genetic changes that ... information to develop targeted treatments. But achieving this goal ... and a sophisticated infrastructure to manage and analyze the ...
... Lewin has been elected to the National Academy of Sciences ... in the Department of Animal Sciences and founding director of ... he conducted during his 27 years at the University of ... University of California, Davis, where he earned his doctorate in ...
... 1, 2012)A recent study published in the May/June 2012 ... journal of the Academy of General Dentistry, found that ... energy drinks, especially among adolescents, is causing irreversible damage ... erode tooth enamel, the glossy outer layer of the ...
Cached Biology News:UC Santa Cruz builds national data center for cancer genome research 2UC Santa Cruz builds national data center for cancer genome research 3UC Santa Cruz builds national data center for cancer genome research 4UC Santa Cruz builds national data center for cancer genome research 5Harris Lewin elected to National Academy of Sciences 2Sports and energy drinks responsible for irreversible damage to teeth 2
... Detection System combines the indirect labeling ... and Signets unique formulation of ultra ... reliablility. Signet reagents will achieve excellent ... automated protocols. ,Signets USA Detection ...
6X Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
6X DNA Gel Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
Biology Products: